North America Biochips Market by Type (DNA Chips, Lab-On-A-Chip, Protein Chips, and Others), by End User (Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, Academic & Research Institutes), by Fabrication Technology (Microfluidics and Microarrays) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

North America Biochips Market by Type (DNA Chips, Lab-On-A-Chip, Protein Chips, and Others), by End User (Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, Academic & Research Institutes), by Fabrication Technology (Microfluidics and Microarrays) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1631 | Pages: 137 | November 2016 | Region: North America


The North America Biochips Market was worth $2.30 billion in 2016 and estimated to be growing at a CAGR of 22.64%, to reach $6.39 billion by 2021. The medicinal importance of miniaturised biological microarray chips, generally known as biochips, has produced a transforming effect on the global healthcare industry. The extensive variety of biochip applications and products have propelled the growth of the market at an extraordinary level.

Biochip products consist of microarrays of biochemical particles, which are assembled on a silicon or glass plate. These devices have functions in gene sequencing, proteomics, genomics, clinical diagnosis, and drug discovery.

The growth of the North America Biochips market is mainly due to factors such as rise in the utilization of personalized medicine, demand for high speed diagnostics and increasing government funding. In addition, growing healthcare awareness is also boosting the growth of the biochips market. However, inadequate technical awareness related to biochips, low acceptance due to high cost and accessibility to alternate technologies are some of the major factors limiting the growth of the market in this region.

The North America Biochips market is segmented based on Type, End User, and Fabrication Technology. The market for Biochips, on the basis of Type is segmented into DNA Chips, Lab-On-A-Chip, and Protein Chips. DNA Chips are further segmented into SNP Genotyping, Genomics, Agricultural Biotechnology, Gene Expression, Cancer Diagnosis & Treatment, Drug Discovery, and Others. Lab-On-A-Chips are further segmented into Clinical Diagnostics, IVD & POC, Drug Discovery, Genomics, and Proteomics. Protein Chips are further segmented into Expression Profiling, High-Throughput Screening, Proteomics, Diagnostics, and Drug Discovery. On the basis of type, DNA Chips are the largest segment, followed by lab-on-chips and protein biochips market, due to development in the proteomics and genomics field. However, enhancement in the field of recombinant proteins would assist the growth of protein biochips market. On the basis of End User, the Biochips market is segmented into Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, Academic & Research Institutes. The Hospitals and Diagnostics Center segment dominates the market, as it is primarily driven by various factors such as increasing government funding and technological advancements.

The North America market has been geographically segmented into segmented into US and Canada. North America is leading the global Biochips market due to technological advancements and a large pool of ageing populace.  The North America market leads the global market and is very modern and is focused on innovating cost-effective chips.

The recent developments in the global biochips market include the outsourcing of biochips technology, which would aid in decreasing labor cost and capital prerequisites. The major companies dominating the Biochips market in this region are Agilent Technologies Inc., Fluidigm Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., GE Healthcare, Cepheid Inc., Illumina Inc., and Thermo Fisher Scientific Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 DNA Chips

                                                5.1.2.1 SNP Genotyping

                                                5.1.2.2 Genomics

                                                5.1.2.3 Agricultural Biotechnology

                                                5.1.2.4 Gene Expression

                                                5.1.2.5 Cancer Diagnosis & Treatment

                                                5.1.2.6 Drug Discovery

                                                5.1.2.7 Others

                                5.1.3 Lab-On-A-Chip      

                                                5.1.3.1 Clinical Diagnostics

                                                5.1.3.2 IVD & POC

                                                5.1.3.3 Drug Discovery

                                                5.1.3.4 Genomics

                                                5.1.3.5 Proteomics

                                5.1.4 Protein Chips         

                                                5.1.4.1 Expression Profiling

                                                5.1.4.2 High-Throughput Screening

                                                5.1.4.3 Proteomics

                                                5.1.4.4 Diagnostics

                                                5.1.4.5 Drug Discovery

                                5.1.5 Other types            

                                5.1.6 Y-o-Y Growth Analysis, By Type      

                                5.1.7 Market Attractiveness Analysis, By Type     

                                5.1.8 Market Share Analysis, By Type      

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospitals and Diagnostics Centers

                                5.2.3 Biotechnology and Pharmaceutical Companies       

                                5.2.4 Academic & Research Institutes    

                                5.2.5 Y-o-Y Growth Analysis, By End User              

                                5.2.6 Market Attractiveness Analysis, By End User            

                                5.2.7 Market Share Analysis, By End User              

                5.3 Fabrication Technology                         

                                5.3.1 Introduction           

                                5.3.2 Microfluidics          

                                5.3.3 Microarrays            

                                5.3.4 Y-o-Y Growth Analysis, By Fabrication Technology

                                5.3.5 Market Attractiveness Analysis, By Fabrication Technology                

                                5.3.6 Market Share Analysis, By Fabrication Technology

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By End User

                                                6.1.3.4 By Fabrication Technology

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By End User

                                                6.1.4.4 By Fabrication Technology

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By End User

                                                6.1.5.4 By Fabrication Technology

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Athersys                      

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 StemCells                    

                8.3 Cryo Cell International                           

                8.4 Geron Corporation                  

                8.5 Mesoblast                  

                8.6 Aastrom Biosciences                               

                8.7 Celgene Corporation                              

                8.8 Invitrogen                   

                8.9 Cytori Therapeutics                 

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market

TitlePriceAdd To Cart
  1. North America Biochips Market By Region, From 2016-2021 (USD Billion)
  2. North America Biochips Market By Type, From 2016-2021 (USD Billion)
  3. North America DNA Chips Market By Region, From 2016-2021 (USD Billion)
  4. North America Biochips Market By DNA Chips, From 2016-2021 (USD Billion)
  5. North America SNP Genotyping Market By Region, From 2016-2021 (USD Billion)
  6. North America Genomics Market By Region, From 2016-2021 (USD Billion)
  7. North America Agricultural Biotechnology Market By Region, From 2016-2021 (USD Billion)
  8. North America Gene Expression Market By Region, From 2016-2021 (USD Billion)
  9. North America Cancer Diagnosis & Treatment Market By Region, From 2016-2021 (USD Billion)
  10. North America Drug Discovery Market By Region, From 2016-2021 (USD Billion)
  11. North America Other DNA chips Market By Region, From 2016-2021 (USD Billion)
  12. North America Lab-On-A-Chip Market By Region, From 2016-2021 (USD Billion)
  13. North America Biochips Market By Lab-On-A-Chip, From 2016-2021 (USD Billion)
  14. North America Clinical Diagnostics Market By Region, From 2016-2021 (USD Billion)
  15. North America IVD & POC Market By Region, From 2016-2021 (USD Billion)
  16. North America Drug Discovery Market By Region, From 2016-2021 (USD Billion)
  17. North America Genomics Market By Region, From 2016-2021 (USD Billion)
  18. North America Proteomics Market By Region, From 2016-2021 (USD Billion)
  19. North America Protein Chips Market By Region, From 2016-2021 (USD Billion)
  20. North America Other types Market By Region, From 2016-2021 (USD Billion)
  21. North America Biochips Market By Protein Chips, From 2016-2021 (USD Billion)
  22. North America Expression Profiling Market By Region, From 2016-2021 (USD Billion)
  23. North America High-Throughput Screening Market By Region, From 2016-2021 (USD Billion)
  24. North America Proteomics Market By Region, From 2016-2021 (USD Billion)
  25. North America Diagnostics Market By Region, From 2016-2021 (USD Billion)
  26. North America Drug Discovery Market By Region, From 2016-2021 (USD Billion)
  27. North America Biochips Market By End User , From 2016-2021 (USD Billion)
  28. North America Hospitals and Diagnostics Centers Market By Region, From 2016-2021 (USD Billion)
  29. North America Biotechnology and Pharmaceutical Companies Market By Region, From 2016-2021 (USD Billion)
  30. North America Academic & Research Institutes Market By Region, From 2016-2021 (USD Billion)
  31. North America Biochips Market By Fabrication Technology , From 2016-2021 (USD Billion)
  32. North America Microfluidics Market By Region, From 2016-2021 (USD Billion)
  33. North America Microarrays Market By Region, From 2016-2021 (USD Billion)
  34. United States Biochips Market By Type, From 2016-2021 (USD Billion)
  35. United States Biochips Market By DNA Chips, From 2016-2021 (USD Billion)
  36. United States Biochips Market By Lab-On-A-Chip, From 2016-2021 (USD Billion)
  37. United States Biochips Market By Protein Chips, From 2016-2021 (USD Billion)
  38. United States Biochips Market By End User , From 2016-2021 (USD Billion)
  39. United States Biochips Market By Fabrication Technology , From 2016-2021 (USD Billion)
  40. Canada Biochips Market By Type, From 2016-2021 (USD Billion)
  41. Canada Biochips Market By DNA Chips, From 2016-2021 (USD Billion)
  42. Canada Biochips Market By Lab-On-A-Chip, From 2016-2021 (USD Billion)
  43. Canada Biochips Market By Protein Chips, From 2016-2021 (USD Billion)
  44. Canada Biochips Market By End User , From 2016-2021 (USD Billion)
  45. Canada Biochips Market By Fabrication Technology , From 2016-2021 (USD Billion)

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, kakatiya's empire,
Jubilee Gardens,
Hyderabad, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.